Blog Category:

Visualizing the Future: Advances in IL-23-Targeted Therapies in the Treatment of IBD

The inflammatory cytokine interleukin (IL)-23 has been implicated in the pathology of inflammatory bowel disease (IBD), a chronic inflammatory condition of the gastrointestinal tract. The stimulation of pathogenic Th-17 cell formation by IL-23 and the subsequent ongoing bowel inflammation via …

Shedding Light on Bowel Urgency: Presenting the Latest Data and Initiating Conversations in Crohn’s Disease Management

Patients with Crohn’s disease (CD) frequently experience bowel urgency, a symptom resulting in rushing to the bathroom and sometimes causing loss of bowel control. The symptom of bowel urgency dramatically impacts patient quality of life (QoL), and can lead to …

Early Detection, Better Direction: Tau Biomarkers and Amyloid-Targeting Therapies in Alzheimer’s Disease

Due to the rising prevalence and significant burden of Alzheimer’s disease there is a critical need for continuing education aimed at bridging existing gaps in clinician knowledge, competence, and performance concerning novel and emerging amyloid-targeting therapies (ATTs), especially in the …